SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust ($SLV) is surging to unprecedented all-time highs, propelled by tightening global supply due to impending Chinese export restrictions and robust industrial demand from booming sectors like EV batteries, solar, and AI data centers. The community is actively discussing a potential "silver squeeze" and a significant re-rating of silver's value, anticipating further ascent despite some calls for a near-term pullback after its rapid rise.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending intensely due to the imminent launch of its BlueBird 6 satellite, a crucial step in its direct-to-device space broadband mission. While many bulls anticipate significant price appreciation and a shift from promise to execution, bears contend the launch is already priced in, citing the company's current low revenue and high valuation. This event is a focal point within the actively discussed space sector.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending intensely as the market anticipates clarity from its recent FDA Type B meeting for Sonelokimab in Hidradenitis Suppurativa. The community is abuzz with strong expectations for a positive regulatory path, driving significant speculation about a potential acquisition by a major pharmaceutical company at a substantial premium. Amidst discussions of market manipulation and the drug's best-in-class potential, many investors are holding firm, viewing the asset as profoundly undervalued.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is trending as gold recently surged to new all-time highs, fueling a polarized discussion among investors. Many are bullish, citing geopolitical tensions, a weakening dollar, and expectations of central bank easing as catalysts driving its appeal as a safe-haven asset. Conversely, others express concern, labeling the rapid ascent a potential bubble and a warning signal for broader economic instability, often comparing its performance to silver and bitcoin.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is a prominent trending stock, fueled by its upcoming inclusion in the S&P MidCap 400, which is sparking community excitement for potential institutional buying. Investors are increasingly bullish on its strong fundamentals, highlighting consistent profitability, a robust balance sheet with no debt, and its leading position in the burgeoning agentic AI sector. The market is actively discussing its long-term growth potential and perceived undervaluation within the automation landscape.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

AVNT CRYPTO is generating significant buzz following its recent listing on Robinhood and its strong association with Coinbase, with community members actively discussing upcoming features like an AI trading bot and 500x leveraged perps on the Base app. Despite some historical skepticism, many traders are speculating on its potential for substantial gains, positioning it as a challenger to leading decentralized exchanges within the altcoin space.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in Sarnia, Canada.

Aduro Clean Technologies Inc

Aduro Clean Technologies is trending following the closing of a US$20 million public offering, which bulls view as crucial funding for its demonstration plant and a strong signal of confidence in its Hydrochemolytic Technology. This comes amidst community discussion on the recent Shell GameChanger graduation and successful pilot trials for converting waste plastics into oil. However, skeptics continue to label the pre-revenue company as a "pump and dump," questioning its valuation and the economic viability of its technology despite ongoing partnerships and validations in the clean tech sector.

abrdn ETF - abrdn Physical Platinum Shares ETF

abrdn Physical Platinum Shares ETF is surging, propelled by a potent combination of tight supply from key mining regions and robust demand from industrial uses like automotive catalysts and green energy, alongside increased investment. The community is captivated by this extraordinary rally, with many anticipating platinum's continued ascent as it aims to reclaim its historical valuation relative to gold.

TOSHI

TOSHI is actively trending as its community, known for rallying around the 'blue cat' identity, continues to emphasize its foundational role as the 'Face of Base' within the Coinbase ecosystem. Despite broader market volatility, investors are aggressively accumulating, viewing current price levels as an oversold opportunity for significant future upside, fueled by ongoing speculation about major exchange listings and long-term growth.

Sprott Physical Silver Trust - Units

Sprott Physical Silver Trust ET

Sprott Physical Silver Trust (PSLV) is trending as silver surges to new all-time highs, driven by a significant structural supply deficit and booming industrial demand from sectors like EVs and AI. The community is buzzing with talk of a massive short squeeze, with many advocating for PSLV over other vehicles due to its physical silver backing amidst growing concerns about market manipulation and geopolitical instability. Investors view silver as a critical asset and a strong hedge in the current economic climate.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neurocrine Biosciences Provides Update on Phase 3 Study of Valbenazine in Dyskinetic Cerebral Palsy

Neurocrine Biosciences Provides Update on Phase 3 Study of Valbenazine in Dyskinetic Cerebral Palsy Neurocrine Biosciences Provides Update on Phase 3 Study of Valbenazine in Dyskinetic Cerebral Palsy...

Assenagon Asset Management S.A. Sells 13,280 Shares of Neurocrine Biosciences, Inc. $NBIX

Assenagon Asset Management S.A. cut its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 22.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and...

Neurocrine Biosciences (NASDAQ:NBIX) Director Leslie Norwalk Sells 1,190 Shares

Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Get Free Report) Director Leslie Norwalk sold 1,190 shares of the business's stock in a transaction dated Tuesday, December 16th. The stock was sold at an...

Neurocrine Biosciences (NASDAQ:NBIX) Director Leslie Norwalk Sells 5,000 Shares

Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Get Free Report) Director Leslie Norwalk sold 5,000 shares of the stock in a transaction on Monday, December 15th. The stock was sold at an average price...

Neurocrine Biosciences (NASDAQ:NBIX) Stock Price Expected to Rise, HC Wainwright Analyst Says

HC Wainwright increased their target price on shares of Neurocrine Biosciences from $168.00 to $198.00 and gave the stock a "buy" rating in a research note on Wednesday...

Texas Permanent School Fund Corp Sells 11,976 Shares of Neurocrine Biosciences, Inc. $NBIX

Texas Permanent School Fund Corp cut its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 18.2% in the 2nd quarter, according to its most recent filing with the Securities and...

Neurocrine Biosciences Showcases R&D Transformation Driving Innovation Across Neuroscience and Endocrinology

Neurocrine Biosciences Showcases R&D Transformation Driving Innovation Across Neuroscience and Endocrinology Neurocrine Biosciences Showcases R&D Transformation Driving Innovation Across Neuroscience...

Hudson Bay Capital Management LP Has $9.75 Million Stake in Neurocrine Biosciences, Inc. $NBIX

Hudson Bay Capital Management LP trimmed its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 48.4% during the 2nd quarter, according to the company in its most...

Neurocrine Biosciences (NASDAQ:NBIX) Stock Price Expected to Rise, Mizuho Analyst Says

Mizuho upped their target price on shares of Neurocrine Biosciences from $146.00 to $175.00 and gave the company a "neutral" rating in a research note on Friday...

Boone Capital Management LLC Makes New Investment in Neurocrine Biosciences, Inc. $NBIX

Boone Capital Management LLC bought a new stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with...

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

NBIX
Neurocrine Biosciences, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NBIX News

NBIXNeurocrine Biosciences, Inc.